Relationship between melatonin receptor 1B and insulin receptor substrate 1 polymorphisms with gestational diabetes mellitus: A systematic review and meta-analysis

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Zhang, Yan ^a   Sun, Cheng Ming ^b   Hu, Xiang Qin ^c   Zhao, Yue ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

^c Tianjin Central Hospital of Gynecology and Obstetrics   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE; MELATONIN 2 RECEPTOR; MTNR1B PROTEIN, HUMAN;

ALLELE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; META ANALYSIS; PREGNANCY; PREGNANCY DIABETES MELLITUS; PUBLISHING; RISK;

ALLELES; DIABETES, GESTATIONAL; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; ODDS RATIO; POLYMORPHISM, GENETIC; PREGNANCY; PUBLICATION BIAS; RECEPTOR, MELATONIN, MT2;

EID: 84906667787     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06113     Document Type: Article

References (49)

1. Coustan, D. R. Gestational diabetes mellitus. Clin Chem 59, 1310-1321 (2013).
2. Reece, E. A., Leguizamon, G. & Wiznitzer, A. Gestational diabetes: the need for a common ground. Lancet 373, 1789-1797 (2009).
3. Ohara-Imaizumi, M. et al. Serotonin regulates glucose-stimulated insulin secretion from pancreatic b cells during pregnancy. Proc. Natl. Acad. Sci. USA 110, 19420-19425 (2013).
4. Association, A. D. Diagnosis and classification of diabetes mellitus. Diabetes Care 35, S64-S71 (2012).
5. Kim, S. Y. et al. Racial/ethnic differences in the prevalence of gestational diabetes mellitus and maternal overweight and obesity, by Nativity, Florida, 2004-2007. Obesity 21, E33-E40 (2013).
6. Shaat, N. & Groop, L. Genetics of gestational diabetes mellitus. Curr Med Chem 14, 569-583 (2007).
7. Hunt, K. J. & Schuller, K. L. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 34, 173-199 (2007).
8. Alberti, K. G. & Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539-553 (1998).
9. Cho, Y. et al. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 52, 253-261 (2009).
10. Hara, K. et al. Genome-wide association study identifies three novel loci for type 2 diabetes. Hum Mol Gen 23, 239-246 (2014).
11. Peschke, E. Melatonin, endocrine pancreas and diabetes. J Pineal Res 44, 26-40 (2008).
12. Ekmekcioglu, C. & Thalhammer, T. in Melatonin and Melatonergic Drugs in Clinical Practice 1-15 (Springer, 2014).
13. Gupta, P. P., Nanavaty, V. & Shah, P. Homology modeling of mtnr1b and insilico structure activity relationship study of melatonin analogs for therapeutic application in insomnia and insomnia related diabetes. Int J Pharma & Bio Sciences 4 (2013).
14. Pandi-Perumal, S. R. et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 85, 335-353 (2008).
15. Rönn, T. et al.Acommon variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia 52, 830-833 (2009).
16. Xia, Q. et al. Association between the melatonin receptor 1B gene polymorphism on the risk of type 2 diabetes, impaired glucose regulation: a meta-analysis. PloS one 7 (2012).
17. Sun, X. J. et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73-77 (1991).
18. Mima, A. et al. Glomerular-specific protein kinase C-b-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney Int 79, 883-896 (2011).
19. Tang, Y. et al. Association study of a common variant near IRS1 with type 2 diabetes mellitus in Chinese Han population. Endocrine 43, 84-91 (2013).
20. Deng, Z. et al. Association of genetic variant rs10830963 of melatonin receptor 1B gene in women with gestational diabetes mellitus. Zhonghua Wei Chan Yi Xue Za Zhi 14, 666-669 (2011).
21. Wang, Y. et al. Association of six single nucleotide polymorphisms with gestational diabetes mellitus in a Chinese population. PLoS One 6, e26953 (2011).
22. Kim, J. Y. et al.Melatonin receptor 1 B polymorphisms associated with the risk of gestational diabetes mellitus. BMC Med Genet 12, 82 (2011).
23. Vlassi, M. et al. The rs10830963 variant of melatonin receptor MTNR1B is associated with increased risk for gestational diabetes mellitus in a Greek population. Hormones 11, 70-76 (2012).
24. Li, C. et al. Association between Genetic Variations in MTNR1A and MTNR1B Genes and Gestational Diabetes Mellitus in Han Chinese Women. Gynecol. Obstet. Invest 76, 221-227 (2013).
25. Pappa, K. I. et al. Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population. Gynecol Endocrinol 27, 267-272 (2011).
26. Alharbi, K. K., Khan, I. A., Abotalib, Z. & Al-Hakeem, M. M. Insulin Receptor Substrate-1 (IRS-1) Gly927Arg: Correlation with Gestational Diabetes Mellitus in Saudi Women. Biomed Res Int 2014, 1-5 (2014).
27. Fallucca, F. et al. Polymorphisms of insulin receptor substrate 1 and b3-adrenergic receptor genes in gestational diabetes and normal pregnancy. Metabolism 55, 1451-1456 (2006).
28. Tok, E. C. et al. Association of insulin receptor substrate-1 G972R variant with baseline characteristics of the patients with gestational diabetes mellitus. Am. J. Obstet. Gynecol 194, 868-872 (2006).
29. Shaat, N. et al. Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus. Diabetologia 48, 2544-2551 (2005).
30. Metzger, B. E. Summary and recommendations of the third international workshop-conference on gestational diabetes mellitus. Diabetes 40, 197-201 (1991).
31. Silverman, B. L., Rizzo, T. A., Cho, N. H. &Metzger, B. E. Long-term effects of the intrauterine environment. The Northwestern University Diabetes in Pregnancy Center. Diabetes care 21, B142-149 (1998).
32. Järvelä, I. Y. et al. Gestational Diabetes Identifies Women at Risk for Permanent Type 1 and Type 2 Diabetes in Fertile Age Predictive role of autoantibodies. Diabetes Care 29, 607-612 (2006).
33. Leader, N. J. Gestational diabetes mellitus. Nutridate 23, 2 (2012).
34. Metzger, B. E. et al. Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes care 30, S251-S260 (2007).
35. Lambrinoudaki, I., Vlachou, S. A. & Creatsas, G. Genetics in gestational diabetes mellitus: association with incidence, severity, pregnancy outcome and response to treatment. Curr Diabetes Rev 6, 393-399 (2010).
36. Liao, S. et al. Association of genetic variants of melatonin receptor 1B with gestational plasma glucose level and risk of glucose intolerance in pregnant Chinese women. PloS one 7, e40113 (2012).
37. Prokopenko, I. et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 41, 77-81 (2009).
38. Langenberg, C. et al. Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia 52, 1537-1542 (2009).
39. Takeuchi, F. et al. Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations. Diabetologia 53, 299-308 (2010).
40. Tam, C. H. T. et al. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects. PloS one 5, e11428 (2010).
41. Lyssenko, V. et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. NAT GENET 41, 82-88 (2009).
42. Sun, X. J. et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73-77 (1991).
43. Stephens, J. M., Lee, J. & Pilch, P. F. Tumor necrosis factor-a-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J. Biol. Chem 272, 971-976 (1997).
44. Jellema, A., Zeegers, M., Feskens, E., Dagnelie, P. & Mensink, R. Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies. Diabetologia 46, 990-995 (2003).
45. Morini, E. et al. IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of 'lowfrequency-low-risk'variants. Diabetologia 52, 1852-1857 (2009).
46. Kaburagi, Y. et al. The mechanism of insulin-induced signal transduction mediated by the insulin receptor substrate family. ENDOCR J 46, S25-34 (1999).
47. Williams, M. A., Qiu, C., Dempsey, J. C. & Luthy, D. A. Familial aggregation of type 2 diabetes and chronic hypertension in women with gestational diabetes mellitus. J Reprod Med 48, 955-962 (2003).
48. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. CONTROL CLIN TRIALS 7, 177-188 (1986).
49. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719-748 (1959).